This antibody targets the 56 kDa GFAP protein, a key component of intermediate filaments in glial cells and astrocytes. It aids in distinguishing glial tumors like astrocytomas and ependymomas from other types such as meningiomas, neuroblastomas, chordomas, chondrosarcomas, lymphomas, and carcinomas.